ALBANY, New York, June 3, 2014 /PRNewswire/ -- Albany
Molecular Research Inc. (NASDAQ: AMRI) announced today that
William S. Marth, President and
Chief Executive Officer at AMRI, will present at the 2014 Wells
Fargo Healthcare Conference on Tuesday, June
17, 2014 at 10:00 a.m. ET.
A webcast of the presentation can be accessed at the Investor
Relations' section of www.amriglobal.com, or at the following URL:
http://cc.talkpoint.com/well001/061714a_ac/?entity=41_IMTDU1O
The webcast will be archived for 90 days following the live
presentation.
About AMRI
Albany Molecular Research Inc.
(AMRI) is a global contract research and manufacturing organization
that has been working with the Life Sciences industry to improve
patient outcomes and the quality of life for more than two decades.
With locations in North America,
Europe and Asia, our key business units include Large
Scale Manufacturing (LSM) and Discovery and Development Solutions
(DDS). The LSM business unit includes API and Drug Product
Manufacturing, which supports the commercial cGMP manufacturing of
complex APIs, starting materials, clinical formulation development
and aseptic fill and finish. Our DDS unit provides comprehensive
services from hit identification to IND, including expertise with
diverse chemistry, library design and synthesis, in
vitro biology and pharmacology, drug metabolism and
pharmacokinetics, as well as natural products. For more information
about AMRI, please visit our website at www.amriglobal.com or
follow us on Twitter (@amriglobal).